Thrombin Test Detects Low Risk of Recurrent Blood Clots - CME Teaching Brief� - MedPage Today
Review
VIENNA, Austria, July 26 -- Patients with a first venous thromboembolism but a thrombin generation of less than 400 nM had a 60% lower risk of a recurrent leg or lung clot, according to a study here.
Measurement of thrombin generation can help determine which patients with venous thromboembolism (VTE) are at low risk for recurrence and can therefore avoid extensive testing and the bleeding risks of anticoagulant treatment, researchers wrote in the July 26 issue of the Journal of the American Medical Association.
Posted by gruwell at July 27, 2006 7:52 AM | TrackBack